NCT06564389View on ClinicalTrials.gov

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

PHASE1RecruitingINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

June 2, 2027

Study Completion Date

June 2, 2027

Conditions

Healthy ParticipantsAtopic Dermatitis

Interventions

DRUG

PF-07832837

escalated doses of PF-07832837

OTHER

Placebo

placebo

Trial Locations (1)

92801

RECRUITING

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT06564389 - FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients | Biotech Hunter | Biotech Hunter